Actively Recruiting
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Led by Bristol-Myers Squibb · Updated on 2026-02-03
413
Participants Needed
21
Research Sites
202 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to test the safety and efficacy of BMS-986482 alone and as combination therapy in participants with advanced solid tumors.
CONDITIONS
Official Title
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must have a confirmed advanced, unresectable or metastatic solid tumor measurable by RECIST v1.1 and have received, are refractory to, ineligible for, intolerant of, or have refused therapies known to provide clinical benefit.
- Participants must be 18 years or older or the legal age of consent in their location at the time of signing the consent form.
You will not qualify if you...
- History of life-threatening immune-mediated toxicity related to prior T-cell agonist or checkpoint inhibitor therapy, except if unlikely to recur with standard treatment.
- Any significant acute or chronic medical illness that could interfere with the study treatment or follow-up according to the investigator.
- Other protocol-defined inclusion or exclusion criteria apply.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 21 locations
1
University of California, Irvine (UCI) Health - UC Irvine Medical Center
Irvine, California, United States, 92612
Actively Recruiting
2
The Angeles Clinic and Research Institute - West Los Angeles Office
Los Angeles, California, United States, 90025
Actively Recruiting
3
Local Institution - 0008
Aurora, Colorado, United States, 80045
Not Yet Recruiting
4
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
Actively Recruiting
5
Northwell Health/ RJ Zuckerberg Cancer Center
Lake Success, New York, United States, 11042
Actively Recruiting
6
Levine Cancer Institute
Charlotte, North Carolina, United States, 28204
Actively Recruiting
7
Fred Hutchinson Cancer Center
Seattle, Washington, United States, 98109
Actively Recruiting
8
UZ Gent
Ghent, Oost-Vlaanderen, Belgium, 9000
Actively Recruiting
9
Rigshospitalet
Copenhagen, Capital Region, Denmark, DK-2100
Actively Recruiting
10
Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone
Marseille, Bouches-du-Rhône, France, 13385
Actively Recruiting
11
Gustave Roussy
Villejuif, Paris, France, 94800
Actively Recruiting
12
General Hospital of Athens "Laiko"
Athens, Attikí, Greece, 11527
Actively Recruiting
13
Papageorgiou General Hospital of Thessaloniki
Thessaloniki, Thessaloníki, Greece, 564 29
Actively Recruiting
14
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy, Italy, 20133
Actively Recruiting
15
Istituto Clinico Humanitas
Rozzano, Milano, Italy, 20089
Actively Recruiting
16
Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI AVL)
Amsterdam, North Holland, Netherlands, 1066 CX
Actively Recruiting
17
Erasmus Medisch Centrum
Rotterdam, Netherlands, 3015 GD
Actively Recruiting
18
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona [Barcelona], Spain, 08035
Actively Recruiting
19
Clinica Universidad de Navarra
Pamplona, Navarre, Spain, 31008
Actively Recruiting
20
Hospital Universitario HM Sanchinarro
Madrid, Spain, 28050
Actively Recruiting
21
Karolinska Universitetssjukhuset Solna
Solna, Stockholms Län [se-01], Sweden, 171 64
Actively Recruiting
Research Team
B
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
F
First line of the email MUST contain NCT # and Site #.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
9
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here